MedTrace Logo

Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation

NCT05051605 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-02-14

No results posted yet for this study

Summary

A prospective cohort study to evaluate the response to COVID-19 vaccine in liver transplantation patients.

Conditions

  • Liver Transplant

Interventions

BIOLOGICAL

COVID-19 Vaccine

Severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2)vaccine according to vaccine availability in the Egyptian ministry of health.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Rana Sayed, PhD · Faculty of Pharmacy, Ain Shams University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2023-06-30
Completion
2023-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05051605 on ClinicalTrials.gov